本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
BEIJING, May 12, 2025 /PRNewswire/ -- Langjiu, a leading Chinese Baijiu brand of sauce aroma, has been unveiled on Saturday night as one of the most-favored Chinese brands voted by foreigners in the activity "Give a Like for My Favorite China's Brands (2024-2025)". It secured the most votes by foreigners in the baijiu category, highlighting its strong appeal among overseas markets and global consumers. Co-organized by the Brand Work Office of Xinhua News Agency and China Economic Information Service (CEIS), the global online voting campaign for "Give a Like for My Favorite China's Brands (2024-2025)" has been successfully held for four consecutive years. The annual activity aims to showcase the competitiveness and global influence of Chinese brands, while further enhancing recognition and popularity among foreigners. The photo shows Qinghualang, the flagship product of Langjiu. Langjiu is produced in Erlang Town, Gulin County, southwest China's Sichuan Province, which is located on the left bank of the Chishui River, one of the world's top ten liquor-producing regions. The company has built the Langjiu Estate in this area, encompassing six ecological brewing zones, spanning 49km along the riverbank. With an annual production capacity of 72,000 tons of premium sauce-aroma baijiu and a storage volume of 265,000 tons, the estate attracts over 200,000 baijiu enthusiasts from around the world each year. Aerial photo shows the Langjiu Estate in southwest China's Sichuan Province. According to the World Brand Summit 2024 report on China's 500 Most Valuable Brands, Langjiu ranked 56th with a brand value of 151.876 billion yuan (around 20.98 billion U.S. dollars), securing a top-three position in the Chinese baijiu industry for 16 consecutive years. In recent years, Langjiu has expanded its international business footprint to more than 20 countries and regions across the Americas, Europe, Southeast Asia, and East Africa. Through product launches and promotional events, Langjiu has gradually entered into new markets such as Spain, France, Thailand, and Cambodia. The efforts to take Chinese Baijiu go global boils down to fostering cultural recognition, said Wang Junlin, chairman of Langjiu. The company has long been focusing on quality and culture, continuously enhancing its brand identity. The year 2025 marks the ninth anniversary of China Brand Day. China's brands are gaining growing recognition in international markets. Langjiu, as a shining business card of Chinese Baijiu brands, will forge ahead with constant effort to promote going global of Chinese culture and cultivating cultural identity at a large scope. Original link: https://en.imsilkroad.com/p/345552.html
HONG KONG, May 9, 2025 /PRNewswire/ -- CITIC Securities' research department has recently released its inaugural investment value analysis report on Newborn Town (09911.HK), initiating coverage with a "buy" rating and a target price of HK$11. The report underscores Newborn Town's leading position in the global social entertainment industry. The report highlights Newborn Town's extensive operational experience overseas, particularly in the MENA region, and its successful strategy of replicating its product operations and market expansion experiences. The company's app portfolio is now entering a "harvesting phase," with promising growth potential ahead. App Portfolio Fuels Robust Growth, with Replication Strategy Enhancing Competitive Edge CITIC Securities noted that Newborn Town, a global leader in social entertainment, has achieved robust growth in recent years. " Leveraging extensive experience in international markets, the company has effectively implemented its 'replication' strategy and efficiently executed its 'app portfolio' tactic. As a typical product-driven company, Newborn Town is now entering its 'harvesting phase, " the report states. The research report emphasizes that Newborn Town has a clear and synergistic business structure spanning three key segments.. Leveraging its middle platform system, a high proportion of local employees, the growth path combining investment and R&D efforts, and the rapid iteration of AI technology, Newborn Town is able to implement its 'replication' strategy swiftly. This enables the company's new products to accurately meet market demands, quickly establish a presence, and capture the first-mover advantage in the social networking markets at a relatively low cost. According to the report, Newborn Town's pan-audience social business has developed a healthy product hierarchy. The company currently boasts four flagship products. Its established products, MICO and YoHo contribute stable cash flow, while newer offerings, TopTop and SUGO delivered explosive growth in 2024, with revenues increasing by over 100% and 200% year-on-year respectively. CITIC Securities forecasts that, in the short term, TopTop and SUGO are expected to achieve around 50% year-on-year revenue growth in 2025. The company is well-positioned to develop blockbuster products in the medium to long term, leveraging its proven replicability to sustain its business growth. Newborn Town's diverse-audience social business is rapidly expanding in global markets. According to Frost & Sullivan, the global LGBTQ+ population is projected to reach 660 million by 2026, characterized by high income, significant consumption power, and a strong demand for online social interaction. With a high barrier to entry, Newborn Town has secured a significant first-mover advantage by establishing a large and engaged user base. CITIC Securities believes that the company's LGBTQ+ social platform, HeeSay shows significant growth potential. With its expansion into markets such as Southeast Asia, Japan, and South Korea, coupled with its live streaming feature, HeeSay is expected to achieve even greater market penetration. CITIC Securities projects a compound annual growth rate (CAGR) of approximately 25% in revenue from 2025 to 2027. As Newborn Town's social business continues to strengthen, the company has successfully developed a second growth curve by expanding into innovative areas such as mobile gaming and social e-commerce. CITIC Securities believes that by strategically targeting the casual gaming sector—an untapped market with significant potential—and leveraging its innovative product designs and flexible operational strategies, Newborn Town's merge game Alice's Dream: Merge Games has outperformed expectations and is now generating revenue for the listed company. Looking ahead, CITIC Securities projects that, with the accumulation of successful experience, Newborn Town will be able to launch new quality games with shorter recovery cycles, thereby creating another growth curve for the company. CITIC Securities also pointed out the impressive performance of Newborn Town's social e-commerce business. "There's a growing demand for online purchases of HIV medications and sexual wellness products in China. Heer Health, an e-commerce platform focused on the 'Internet + AIDS prevention' scenario, has become the leading online distributor of certain HIV medications, with roughly 50% of the domestic market share. The platform drives growth through its large user base, extensive distribution channels, and rapid delivery capabilities." Target Price Raised to HK$11, Driven by Strong Growth Potential in the Global Emotional Value Sector CITIC Securities sees substantial room for growth in the global social media market. According to Grand View Research, the global social networking market is projected to reach US$310.37 billion by 2030. Notably, regions such as the Middle East and Southeast Asia are recognized as high-potential markets, with low penetration rates yet strong user engagement, making them key areas for future growth. The research report highlights that, driven by the growth of industries like oil, countries in the MENA region enjoy high per capita GDP. However, factors such as the natural environment, religious customs, and cultural norms limit offline social entertainment options, creating a significant demand for online alternatives. With a user base that enjoys both wealth and leisure time, the market for social applications in the MENA region presents substantial growth potential. According to Verified Market Research, the Middle East media and entertainment market is projected to reach US$82 billion by 2032. Meanwhile, Southeast Asia, with its youthful, internet-savvy population and fast-improving digital infrastructure, is expected to see the GMV of digital entertainment reach US$3.4 billion by 2025. CITIC Securities observes that Newborn Town is strategically targeting the social networking segment for strangers, a space currently lacking dominant competitors. As Generation Z becomes the dominant user group, the demand for personalized social networking experiences continues to rise, blurring the lines between social networking and entertainment. Consequently, social products that cater to individual user preferences are likely to see higher user retention. Newborn Town has already established flagship products in live streaming, gaming, and voice chat, and is anticipated to expand further into other sub-segments in the future. The research report highlights Newborn Town's strong financial performance, characterized by sustained growth and robust cash flow. From 2020 to 2024, the company's revenue increased from RMB1.18 billion to RMB 5.09 billion, representing a CAGR of 44.1%. At the same time, the company's profitability has significantly improved, with gross margins for its social business continuing to rise. Operating cash flow remains healthy, and the company's cash reserves are substantial, ensuring ample resources for future expansion. CITIC Securities has highlighted Newborn Town's promising long-term growth, forecasting net profits of RMB 949 million, RMB1.215 billion, and RMB 1.519 billion for 2025-2027. The current price corresponds to price-to-earnings (PE) ratios of 11x, 8x, and 7x, respectively. By using both comparable valuation and discounted cash flow (DCF) methods, CITIC Securities has set a target price of HK$11 per share. Looking ahead, with continued advancements in AI technology, expansion into emerging markets, and the growing momentum of the emotional value sector, Newborn Town well-positioned to reinforce its leadership in the global social entertainment industry. For long-term investors, the current valuation presents an attractive opportunity.
A landmark study recently published in March 2025 by JCO Oncology Advances, demonstrates the potential of K-TRACKTM in monitoring treatment response and assessing recurrence risk among 623 Solid-Tumor Patients of six cancer types (lung, colorectal, breast, gastric, liver, or ovarian cancer).(1) SINGAPORE, April 19, 2025 /PRNewswire/ -- Gene Solutions, a biotechnology company dedicated to advancing precision oncology in Asia, is excited to announce the publication of a pioneering real-world study in JCO Oncology Advances, validating circulating tumor DNA (ctDNA) as a strong prognostic biomarker to effectively monitor patients during cancer management. K-TRACKTM is a breakthrough in affordable tumor profiling and personalized cancer monitoring leveraging ctDNA technology. The study, the first of its kind in Asia, confirms K-TRACKTM's clinical value across both early and advanced stages of cancer. The test can detect residual cancer cells (Minimal Residual Disease – MRD) after radical treatment, predict recurrence months earlier than traditional methods, and monitor treatment responses effectively. This innovative dual assay offers hope to patients in underserved regions where access to advanced diagnostic technologies remains a challenge. Asia represents nearly 50% of global cancer cases, with incidence rates rising at an alarming pace. While some developed markets in the region have seen improvements in cancer mortality rates, Southeast Asia continues to experience high death rates, predominantly driven by cancer recurrence. (2,3) Research has demonstrated the clinical prognostic value of ctDNA in a variety of cancer types both before and after treatment (4). Despite this potential, the adoption of ctDNA testing remains limited due to factors such as high costs, the absence of standardized methods and insufficient clinical utility of real-world data. K-TRACKTM was developed as an affordable, reliable personalized test for monitoring ctDNA across multiple solid tumors. It is designed to facilitate early detection of cancer recurrence and provide real-time monitoring of treatment responses. Validated in both clinical trials and real-world studies, K-TRACKTM is built for meaningful impact in cancer care while ensuring accessibility. Here's how we make it work: Cost-Effective Innovation: K-TRACKTM uniquely combines streamlined tumor profiling of 155 of the most common driver mutations with personalized ctDNA monitoring based on tumor-specific variants, significantly enhancing the affordability and accuracy for routine clinical practice. Comprehensive approach of genomic profiling and minimal residual disease tracking: The initial tumor profiling results guide the selection of targeted therapies and immunotherapies, while subsequent serial ctDNA monitoring provides early prediction of recurrence and assess treatment effectiveness. Designed for Real-World Conditions: K-TRACKTM is engineered to provide reliable results even from challenging samples such as degraded tissue or delayed blood storage, making it ideal for complex clinical settings. Fig 1. ctDNA analysis workflow. For patients at early stage I-III, paired tumor FFPE and WBC DNA samples were sequenced to identify tumor-specic mutations in 155 cancer-associated genes. Top personalized mutations with the highest ranking scores were used to detect ctDNA in plasma samples by mPCR and ultradeep sequencing. For patients at metastatic stage IV, besides personalized mutations, an additional panel of approximately 500 hotspot mutations specific to each cancer type was added to the analysis. Real-world monitoring of ctDNA has proven effective in predicting early cancer recurrence, allowing for timely interventions and improved patient outcomes. In both early and advanced-stage cancer patients, K-TRACKTM has demonstrated high accuracy in predicting recurrence. Following surgery, 84.4% [CA1] of patients with ctDNA-positive results eventually relapsed, while an impressive 96.3% [CA2] of those with ctDNA-negative results remained cancer-free. Moreover, the test could detect relapse up to 5.5-19.5 months earlier than clinical diagnosis by imaging methods. Simultaneously, the six case studies presented illustrated the clinical utility of ctDNA monitoring in predicting treatment response, informing adjuvant chemotherapy decisions, and identifying new resistant mutations to current targeted treatment. Thus, empowering clinicians with real-time, actionable insights to inform treatment decisions. Fig 2. Prognostic value of ctDNA in early-stage cancer. (A-D) Kaplan-Meier analysis of Disease-free survival (DFS) for patients stratified by postoperative ctDNA status. (E) For patients suspected of recurrence, ctDNA results showed concordance of 87.0% with later diagnosis. (F) No correlation between Variant allele frequency (VAF) of ctDNA and time to recurrence was observed in both suspected and routine surveillance cases. A Vision for Equitable Care "Access to cutting-edge, personalized cancer treatment and monitoring—based on tumor genomic profiling— too often depends on where you live or what you can afford," said Dr. Lan N. Tu, Principal Investigator at Gene Solutions. "Our mission with K-TRACKTM is to close that gap by providing an affordable and precise real-time solution for routine clinical use." Gene Solutions is actively investing in two key areas: 1. On-going Clinical Trials and Real-World Studies: The company is conducting comprehensive research to validate the role of ctDNA across various cancer types and treatment stages. This includes evaluating responses to TKIs and immune checkpoint inhibitors (ICIs) in lung cancer, neoadjuvant therapy in breast cancer, total neoadjuvant therapy in rectal cancer, and the use of biomarkers to inform immunotherapy treatment decisions in advanced cancers. 2. Biopharma Collaborations: Gene Solutions is actively pursuing partnerships with biopharmaceutical companies to provide innovative solutions aimed at accelerating drug development across a range of therapeutic modalities. As the scientific evidence supporting ctDNA continues to grow, Gene Solutions is committed to expanding its research and fostering collaborations with current and new partners to explore new applications in cancer care. The company's direction aligns with the FDA's recommendation on ctDNA use as a biomarker in the development of curative-intent therapies for solid tumors which states: "ctDNA as a biomarker has a number of potential regulatory and clinical uses in the early-stage setting that may assist and expedite drug development." (5) About Gene Solutions Gene Solutions, a multinational biotech company in Asia, is leading the way in leveraging advanced AI and ctDNA technologies for innovative cancer detection solutions. The company partners with over 4,500 hospitals and clinics across Southeast Asia and employs a dedicated team of approximately 250 biology experts and technicians out of a total of 700 employees. With more than 50 peer-reviewed publications and over 50 multi-center studies conducted across the region, Gene Solutions is recognized for its proprietary research and CAP-accredited next-generation sequencing (NGS) laboratories in Singapore and Vietnam. By integrating multi-dimensional genomics with AI-driven methodologies, the company is committed to transforming cancer care and improving patient outcomes. Hoang, V.-A.N. et al. (2025) 'Real-World utilization and performance of circulating tumor DNA monitoring to predict recurrence in solid tumors,' JCO Oncology Advances, Volume 2. DOI: 10.1200/OA-24-00084 Huang, J. et al. (2022) 'Cancer incidence and mortality in Asian countries: a trend analysis,' Cancer Control, 29. DOI:10.1177/10732748221095955. Sharma, R. et al. (2024) 'Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study,' The Lancet Regional Health - Southeast Asia, 21, p. 100333. DOI:10.1016/j.lansea.2023.100333. Kobayashi, S. et al. (2025) 'Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testing,' International Journal of Clinical Oncology [Preprint]. DOI:10.1007/s10147-024-02683-0. Use of Circulating Tumor DNA for Curative-Intent Solid Tumor Drug Development. (2024). In Guidance for Industry [Clinical/Medical]. FDA Guidances, Content current as of: 01/17/2025.
SINGAPORE, May 8, 2025 /PRNewswire/ -- Arcfra is proud to announce that it has been named as a Representative Vendor in the 2025 Gartner® Market Guide for Full-Stack Hyperconverged Infrastructure Software. According to Gartner, "Hyperconverged infrastructure software continues to increase in popularity. Infrastructure and IT operations leaders can use this research to determine if an HCI solution consisting of server, storage and network infrastructure management capabilities is a good fit for their organization." Arcfra is committed to help enterprises effortlessly build robust on-premises cloud and AI infrastructure. The flagship product offering, Arcfra Enterprise Cloud Platform (AECP), is designed to unify compute, storage, networking, security, and disaster recovery capabilities into a single, modular stack. AECP supports both traditional virtual machine-based workloads and modern containerized applications on Kubernetes, with enhanced support for AI/LLM applications. The platform includes built-in automation, observability, and API integrations to simplify management across hybrid environments. "We are excited to be recognized by Gartner in the 2025 Market Guide for Full-Stack HCI Software," said Wenhao Xu, Co-founder and CEO at Arcfra. "We believe this recognition reflects our vision of delivering agile, cost-effective, and future-ready infrastructure to enterprises navigating the post-VMware era." "The ongoing evolution of full-stack HCI software has positioned it as a potential path for not just replacing incumbent HCI vendors, but also as a method of changing virtualization providers in the face of disruption in the broader virtualization market," says Gartner. A lot of I&O leaders are considering moving away from VMware due to the acquisition by Broadcom. Gartner report, A Guide to Choosing a VMware Alternative in the Wake of Broadcom Acquisition, also identified Arcfra as one of the Sample Vendors for Hyperconverged Infrastructure (HCI). Discover how Arcfra can help simplify your cloud and AI infrastructure at www.arcfra.com . Disclaimer Gartner, Market Guide for Full-Stack Hyperconverged Infrastructure Software, April 30 2025. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
MUNICH, May 9, 2025 /PRNewswire/ -- Envision Energy, a global leader in green technology, released its 2025 Net Zero Action Report at the Smarter E Europe in Munich, reaffirming its commitment to climate leadership. The company achieved operational carbon neutrality for the third consecutive year since 2022 and reached 100% renewable electricity use in 2024, fulfilling its RE100 commitment a year ahead of schedule. The report reveals that Envision's Scope 1 and 2 greenhouse gas emissions totaled just 7,089 tonnes CO₂ equivalent in 2024. Against a baseline of 84,000 tonnes, the company reduced emissions by 91%—approximately 77,000 tonnes—through enhanced energy efficiency and the use of both on-site and off-site renewable electricity. By the end of 2024, Envision's delivered products are estimated to have avoided approximately 2.35 billion tonnes of global carbon emissions. Advancing New Benchmarks in Net-Zero Supply Chains and Product Carbon Footprints Envision made building a sustainable supply chain a core pillar of its sustainability strategy, driving green transformation through digital empowerment and the integration of net-zero technologies. By 2024, all its key suppliers had joined Envision's EnOS Ark Carbon Management System, with 18% already using 100% green electricity to supply products to Envision. The company aims for full green power adoption across its core supply chain by 2028. Envision is leveraging its leadership in carbon footprint management to drive industry-wide progress through the International ILCD Life Cycle Data Network, partnering with battery and PV sectors to build international standardized product carbon footprint databases. This initiative helps close critical data gaps and empowers more companies to reshape their value chains and boost global competitiveness. Envision's green hydrogen and ammonia project in Chifeng became one of the first globally to be certified by Bureau Veritas as renewable ammonia. At Smarter E Europe 2025, Envision received TÜV SÜD's Carbon Footprint Certification for its Euro-standard industrial and commercial energy storage cabinet, marking the first publicly disclosed certification of its kind and setting a new industry benchmark. Pioneering Net-Zero Industrial Park Model with AI at the Core At the core of Envision's transformation is the deep integration of AI technologies across its renewable energy products. By combining AI algorithms with full-stack technologies, Envision has built an AI wind turbine system with a closed-loop "perception–decision–execution–evolution"model. This system enables real-time optimization of renewable energy output and grid absorption. AI models for forecasting weather, risk, pricing, and power trading are also reshaping how renewables interact with the power market. As a pioneer of the net-zero industrial park model, Envision is reshaping the global industrial landscape by integrating green energy and green manufacturing into sustainable industrial clusters—with AI at the core. Following the launch of the world's first net zero industrial park in Ordos, Envision Energy's Green Hydrogen-Ammonia Project in Chifeng has commenced production of its first 300,000-tonnes, marking a new milestone for the sector. Meanwhile, its upcoming Net-Zero Hydrogen Industrial Park in Spain will feature hydrogen equipment manufacturing and green hydrogen production to support Europe's decarbonization and industrial transformation. Building on these achievements, Envision plans to replicate this model globally in collaboration with partners, unlocking new opportunities and driving a new era of sustainable prosperity. Forging Cross-Sector Net-Zero Ecosystem In 2024, Envision's global net zero technology partner ecosystem achieved remarkable breakthroughs. Together with Starbucks, Envision transformed the Starbucks Coffee Innovation Park into its most sustainable campus, powered by 100% renewable energy and cutting carbon emissions by approximately 78,000 tonnes annually. With Merck China, Envision is advancing green power procurement and carbon management services, supporting Merck's 2040 climate neutrality goal. In a landmark move,Envision signed a historic green ammonia offtake agreement with Marubeni Corporation, validating its commercial potential and establishing a new global benchmark. From Starbucks to Marubeni, Envision is building a growing, cross-sector net-zero network spanning energy, manufacturing, retail, and logistics—forming a smart, collaborative decarbonization ecosystem. Net zero is not a choice, but a necessity. Envision will continue to join forces with like-minded partners around the world to drive a shared vision of sustainable prosperity and help win the race against the climate challenge.
YIWU, China, May 8, 2025 /PRNewswire/ -- With new U.S. tariff policies driving up the cost of importing and exporting industrial and consumer goods, global supply chains are facing increasing pressure. This shift is accelerating the transition toward localized, distributed manufacturing. In this new environment, 3D print farms—offering faster, more flexible, and cost-efficient production—are seeing unprecedented commercial opportunity. Part of Jinqi Toy 3D print farm Since 2023, 3D print farms have proven to be a highly profitable model in many countries. One standout example is Jinqi Toys, now the world's largest 3D print farm, which demonstrates just how efficient, scalable, and lucrative this approach can be. With 4,000 printers in operation, the company continues to expand at an impressive pace. Jinqi Toys' Success Story Founded in May 2023 in a small Chinese city with just $7,000 in startup capital, Jinqi Toys rose to global prominence in under 18 months, fueled by booming international demand. Today, its 3D-printed toys lead e-commerce rankings across Europe and North America. "Our printers run 24/7, producing 50,000 sets a day, and we still can't keep up with demand," says Hao Zeng, founder of Jinqi. Their success stems from unique product designs, exclusive filament colors, high-speed stable printing, and rapid fulfillment—creating a powerful competitive edge and strong market appeal. "As we grew, managing costs, ROI, and pricing became critical. Reliable, high-performance printers form the backbone of our business. At first, we simply followed trends and purchased whatever models were popular. But soon, we realized that not all printers are built to handle the demands of a print farm." This realization led Jinqi to standardize their operations around Flashforge printers - Amazon's 2024 bestseller in the category. "The Flashforge Adventurer 5M has been transformative for our business," Zeng emphasizes."The value for money is unbeatable. It's fast, uses a stable CoreXY structure, and delivers excellent print quality. One person can manage up to 500 printers via group control—it's incredibly efficient." He adds: "During two sudden power outages, over 90% of our Adventurer 5M prints resumed flawlessly, with no visible seams. That saved us from major losses, while other brands' prints failed entirely." Why Are 3D Print Farms Booming? Just like fast fashion transformed the apparel industry, consumer goods and toy sectors are moving from mass production to small-batch, fast-changing product lines. Traditional manufacturing often requires high upfront investment, expensive molds, long lead times, and large labor forces. 3D printing eliminates these constraints, enabling rapid product iterations, flexible production, and seamless customization—especially for intricate designs and movable parts. As one entrepreneur put it, "A friend started with a few printers, making small batches. As orders grew, he just added more printers and staff. It's a business model that scales easily." Is it Profitable to Build a Small 3D Print Farm in Your Country? Jinqi Toys thrives on China's ultra-low costs—leveraging slim profit margins and large-scale production. But in Europe and North America, entrepreneurs can often achieve higher profit per unit, making solid returns with just a few dozen printers. "If you're new to 3D printing, having a solid business plan is key to building a scalable, sustainable operation," says a Texas-based Etsy seller of 3D-printed dragon eggs."Start with the right printer, but also plan for space, customers, maintenance, labor, and ROI." He's currently considering upgrading to the multicolor Adventurer 5X and shared this estimate based on real sales data (Please refer to table 1, which has been included in the white paper at the end): Table1: Profit estimation with 40 printers Making over $30,000/month with just 40 printers. These cases clearly demonstrate that - with the rise of 3D printing and the impact of new tariffs - a new era of wealth creation through local, distributed manufacturing has begun. Interested in starting your own 3D print farm? Visit: https://flashforge.com/pages/3d-printing-farm Or contact the following email to obtain the '3D Printing Industry White Paper': info@flahforge.com
A12 藝術空間
Survey, Polls & Research
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
